Page 1145 - Williams Hematology ( PDFDrive )
P. 1145
1120 Part VIII: Monocytes and Macrophages
243. Henter JI, Samuelsson-Horne A, Arico M, et al: Treatment of hemophagocytic lympho- 249. Horne A, Janka G, Maarten ER, et al: Haematopoietic stem cell transplantation in hae-
histiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation. mophagocytic lymphohistiocytosis. Br J Haematol 129:622–630, 2005.
Blood 100:2367–2373, 2002. 250. Cooper N, Rao K, Goulden N, et al: The use of reduced-intensity stem cell transplanta-
244. Imashuku S: Treatment of Epstein-Barr virus-related hemophagocytic lymphohistiocy- tion in haemophagocytic lymphohistiocytosis and Langerhans cell histiocytosis. Bone
tosis (EBV-HLH); update 2010. J Pediatr Hematol Oncol 33:35–39, 2011. Marrow Transplant 42 Suppl 2:S47–S50, 2008.
245. Johnson TS, Terrell CE, Millen SH, et al: Etoposide selectively ablates activated T cells 251. Marsh RA, Kim MO, Liu C, et al: An intermediate alemtuzumab schedule reduces the
to control the immunoregulatory disorder hemophagocytic lymphohistiocytosis. J incidence of mixed chimerism following reduced-intensity conditioning hematopoi-
Immunol 192:84–91, 2014. etic cell transplantation for hemophagocytic lymphohistiocytosis. Biol Blood Marrow
246. Thompson PA, Allen CE, Horton T, et al: Severe neurologic side effects in patients being Transplant 19:1625–1631, 2013.
treated for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 52:621–625, 252. Grom AA, Mellins ED: Macrophage activation syndrome: Advances towards under-
2009. standing pathogenesis. Curr Opin Rheumatol 22:561–566, 2010.
247. Mahlaoui N, Ouachee-Chardin M, de Saint BG, et al: Immunotherapy of familial 253. Schulert GS, Grom AA: Macrophage activation syndrome and cytokine-directed ther-
hemophagocytic lymphohistiocytosis with antithymocyte globulins: A single-center apies. Best Pract Res Clin Rheumatol 28:277–292, 2014.
retrospective report of 38 patients. Pediatrics 120:e622–e628, 2007. 254. Lau SK, Chu PG, Weiss LM: Immunohistochemical expression of Langerin in Langer-
248. Marsh RA, Allen CE, McClain KL, et al: Salvage therapy of refractory hemophagocytic hans cell histiocytosis and non-Langerhans cell histiocytic disorders. Am J Surg Pathol
lymphohistiocytosis with alemtuzumab. Pediatr Blood Cancer 60:101–109, 2013. 32:615–619, 2008.
Kaushansky_chapter 71_p1101-1120.indd 1120 9/17/15 3:51 PM

